CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010 by Adnexus, A Bristol-Myers Squibb R&D Company.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Adnexus, A Bristol-Myers Squibb R&D Company
Information provided by:
Adnexus, A Bristol-Myers Squibb R&D Company
ClinicalTrials.gov Identifier:
NCT00768911
First received: October 7, 2008
Last updated: October 26, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2011 |
| Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |